Genizon’s study identified multiple genes associated with the disease using DNA samples from patients from the Quebec founder population.
Michel Maziade, professor of psychiatry at the University of Laval, said: “Schizophrenia is a truly devastating disease for both those afflicted and their families. We expect the results of these studies to lead to a new generation of safer and more effective treatments tailored to individual schizophrenia patients. We are thrilled to be collaborating with Genizon to achieve this goal.”